Immunocore Holdings (IMCR) Receivables (2019 - 2026)
Immunocore Holdings (IMCR) recorded Receivables of $95.4 million in Q2 2026, up 36.7% from $69.8 million a year earlier and up 17.6% from the prior quarter.
Powered by 
Analysis
Immunocore Holdings (IMCR) Receivables (2019 - 2026) Analysis & Trends
At the end of FY2025, Immunocore Holdings reported Receivables of $74 million, up 17.4% from FY2024.
- Annual Receivables has a five-year compound annual growth rate of 36.1% (FY2020 to FY2025).
- Across earlier years, Receivables came in at $63.01 million in FY2024 (+21.0%), $52.09 million in FY2023 (-18.3%), $63.8 million in FY2022 (+178.0%) and $22.95 million in FY2021 (+44.8%).
- The Q2 2026 figure is the highest quarterly Receivables in data going back to Q4 2019.
- On a year-over-year basis, Receivables has increased for seven consecutive quarters, with growth averaging 21.1% over the last seven quarters.
- Peak year-over-year performance for Receivables in the last five years was growth of 183.8% in Q4 2022, against a decline of 18.3% in Q4 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $81.1 million (Q1 2026), $74 million (Q4 2025) and $75.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | 9.64 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | 14.33 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Immunocore Holdings | 1.63 Bn | -1.86 Bn | 114.84 Mn | 95.40 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.40 Mn |
| Mar 31, 2026 | 81.10 Mn |
| Dec 31, 2025 | 74.00 Mn |
| Sep 30, 2025 | 75.90 Mn |
| Jun 30, 2025 | 69.80 Mn |
| Mar 31, 2025 | 63.10 Mn |
| Dec 31, 2024 | 63.01 Mn |
| Sep 30, 2024 | 63.70 Mn |
| Jun 30, 2024 | 60.25 Mn |
| Mar 31, 2024 | 57.80 Mn |
| Dec 31, 2023 | 52.09 Mn |
| Jun 30, 2023 | 68.10 Mn |
| Dec 31, 2022 | 65.58 Mn |
| Sep 30, 2022 | 52.70 Mn |
| Dec 31, 2021 | 22.51 Mn |
| Dec 31, 2020 | 16.36 Mn |
| Dec 31, 2019 | 17.45 Mn |
API Access
Immunocore Holdings Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=IMCR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "IMCR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=IMCR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();